Hikma Pharmaceuticals (HIK)
HIK Share PerformanceMore
|52 week high||2,703.0 02/08/16|
|52 week low||1,575.0 04/11/16|
|52 week change||233.0 (12.42%)|
|4 week volume||12,480,067 29/01/17|
Latest News« previous» nextMore
13/02/2017 - 09:28 StockMarketWire
Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Orion Corporation of Finland, f...
13/02/2017 - 09:19 RNS
RNS Number: 7211W Hikma Pharmaceuticals Plc 13 February 2017 PRESS RELEASE Hikma announces exclusive licensing agreement with Orion for its new Easyhaler product in MENA London, 13 February 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, toda...
06/02/2017 - 14:27 RNS
RNS Number: 1406W Hikma Pharmaceuticals Plc 06 February 2017 Hikma Pharmaceuticals PLC Voting Rights and Capital LONDON, 6 February 2017, Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) notifies the market that its capital consists of 239,971,020 ordinary shares with voting rights. There are nil shares held in treasury. The above figure may...
06/02/2017 - 12:47 RNS
RNS Number: 1324W Hikma Pharmaceuticals Plc 06 February 2017 Notification of major interests in shares LONDON, 6 February 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the fast growing multinational pharmaceuticals group, announces as follows: 1 Identity of the issuer or the underlying issuer of existing shares to which the voting ...
25/01/2017 - 11:00 StockMarketWire
Peel Hunt today initiates coverage of Hikma Pharmaceuticals PLC (LON:HIK) with a buy investment rating and price targ...
18/01/2017 - 09:20 StockMarketWire
Hikma Pharmaceuticals' wholly-owned US subsidiary, Roxane Laboratories, has received an approval for its generic equiv...
18/01/2017 - 09:11 RNS
RNS Number: 4587U Hikma Pharmaceuticals Plc 18 January 2017 Hikma receives approval for Sodium Oxybate Oral Solution London, 18 January 2017 - Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable), the fast growing multinational pharmaceutical group, announces that its whol...
04/01/2017 - 12:00 StockMarketWire
JP Morgan Cazenove today reaffirms its overweight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cu...
Latest discussion posts More
“Thanks for the update Fred, and glad you can tear yourself away from winding everybody up on the IGG board. (They don't like you there do they? What a shame iii did away with ...”▼
“Hi guys, have been busy with projects recently but FYI I just came off the phone with the spread better and as we have not spoke for a few weeks since he sold out, he informed ...”▼
Codes & Symbols
|Symbols||HIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK|